XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Statements of Comprehensive Loss [Abstract]    
Sales $ 1,179,689 $ 1,037,918
Cost of sales 370,384 306,533
Gross margin 809,305 731,385
Operating expenses:    
Research and development 4,084,304 4,130,613
Sales and marketing 208,735 310,219
General and administrative 4,262,002 2,544,043
Depreciation and amortization 591,068 679,653
Total operating expenses 9,146,109 7,664,528
Loss from operations (8,336,804) (6,933,143)
Other income (expense):    
Interest income, net 3,768 22,504
Other income 821,515 10,000
Interest expense (19,226) (12,553)
Other expense (3,098) 0
Total other income 802,959 19,951
Loss before income taxes (7,533,845) (6,913,192)
Income tax expense 4,000 1,800
Net loss (7,537,845) (6,914,992)
Comprehensive loss:    
Net loss (7,537,845) (6,914,992)
Change in fair value of available for sale investments 0 (20)
Total comprehensive loss (7,537,845) (6,915,012)
Net loss attributable to common stockholders, basic (in dollars per share) (7,537,845) (6,914,992)
Net loss attributable to common stockholders, diluted (in dollars per share) $ (7,537,845) $ (6,914,992)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (1.12) $ (7.20)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (1.12) $ (7.20)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 6,712,028 959,862
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 6,712,028 959,862